Filtros de búsqueda

Lista de obras de Maria C Carrillo

18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery

artículo científico publicado en 2018

2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease

artículo científico publicado en 2014

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.

artículo científico publicado en 2009

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

artículo científico publicado en 2016

Adolescent anabolic androgenic steroids reorganize the glutamatergic neural circuitry in the hypothalamus

artículo científico publicado en 2008

Aging effects on memory encoding in the frontal lobes

artículo científico

Alzheimer's Disease prevalence, costs, and prevention for military personnel and veterans

artículo científico publicado en 2014

Alzheimer's disease public-private partnerships: A landscape of the global nonprofit community

artículo científico publicado en 2013

Alzheimer's disease public-private partnerships: update 2014.

artículo científico publicado en 2014

Alzheimer's disease research in Ibero America

artículo científico publicado en 2016

Alzheimer's disease research in the context of the national plan to address Alzheimer's disease

artículo científico

Alzheimer's disease: The next frontier-Special Report 2017.

artículo científico publicado en 2017

Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

scientific article published on 01 November 2020

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup

artículo científico publicado en 2011

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

scientific article published on January 2013

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

artículo científico

Assessing cognition and function in Alzheimer's disease clinical trials: do we have the right tools?

artículo científico publicado en 2014

Assessment of cognition in early dementia

artículo científico publicado en 2011

Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease

artículo científico publicado en 2013

Biomarkers for Alzheimer's disease therapeutic trials

artículo científico publicado en 2010

Building a roadmap for developing combination therapies for Alzheimer's disease

artículo científico publicado en 2015

CAP--advancing the evaluation of preclinical Alzheimer disease treatments

artículo científico publicado en 2015

CSF biomarker variability in the Alzheimer's Association quality control program

artículo científico publicado en 2013

Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease

artículo científico publicado en 2013

Challenges, solutions, and recommendations for Alzheimer's disease combination therapy

artículo científico publicado en 2016

Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease

artículo científico

Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials

artículo científico publicado en 2016

Common Alzheimer's Disease Research Ontology: National Institute on Aging and Alzheimer's Association collaborative project

artículo científico

Commonalities and challenges in the development of clinical trial measures in neurology

artículo científico publicado en 2015

Consensus classification of posterior cortical atrophy

artículo científico publicado en 2017

Considering new treatment paradigms for neuropsychiatric symptoms of Alzheimer's disease

artículo científico publicado en 2016

Cytoskeletal modulators and pleiotropic strategies for Alzheimer drug discovery.

artículo científico publicado en 2006

Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force

artículo científico publicado en 2013

Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010.

artículo científico publicado en 2011

Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.

artículo científico publicado en 2010

Developing novel blood-based biomarkers for Alzheimer's disease

artículo científico publicado en 2014

Developmental and withdrawal effects of adolescent AAS exposure on the glutamatergic system in hamsters

artículo científico publicado en 2011

Down syndrome and Alzheimer's disease: Common pathways, common goals

artículo científico publicado en 2014

Early risk assessment for Alzheimer's disease

artículo científico publicado en 2009

Emotional Mirror Neurons in the Rat's Anterior Cingulate Cortex

Emotional Mirror Neurons in the Rat's Anterior Cingulate Cortex.

artículo científico publicado en 2019

Erratum to: Commonalities and Challenges in the Development of Clinical Trial Measures in Neurology

artículo científico publicado en 2015

Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: a new approach

artículo científico publicado en 2013

Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit

artículo científico publicado en 2016

Everyday technologies for Alzheimer's disease care: Research findings, directions, and challenges

artículo científico publicado en 2009

Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline

artículo científico publicado en 2015

Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation

artículo científico publicado en 2016

Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease

artículo científico publicado en 2016

Global issues in drug development for Alzheimer's disease.

artículo científico publicado en 2011

Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers Consortium

artículo científico publicado en 2012

Glutamate and the aggression neural circuit in adolescent anabolic steroid-treated Syrian hamsters (Mesocricetus auratus).

artículo científico publicado en 2011

Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research

artículo científico publicado en 2015

Imaging markers for Alzheimer disease: which vs how

artículo científico publicado en 2013

Immunohistochemical characterization of 5-HT(3A) receptors in the Syrian hamster forebrain

artículo científico publicado en 2010

Impaired trace eyeblink conditioning in bilateral, medial-temporal lobe amnesia ⬇️

artículo científico publicado el 1 de octubre de 1997

Improving Alzheimer's disease phase II clinical trials

artículo científico publicado en 2012

Intact delay-eyeblink classical conditioning in amnesia

artículo científico publicado en 1995

International Alzheimer's Disease Research Portfolio (IADRP) aims to capture global Alzheimer's disease research funding

artículo científico

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

artículo científico publicado en 2011

Is cognitive decline measurable in preclinical Alzheimer's disease?

artículo científico publicado en 2017

Justifying reimbursement for Alzheimer's diagnostics and treatments: Seeking alignment on evidence

artículo científico publicado en 2014

Leveraging global resources to end the Alzheimer's pandemic

Maximizing the Alzheimer's Disease Neuroimaging Initiative II.

artículo científico publicado en 2009

Measuring cognition and function in the preclinical stage of Alzheimer's disease.

artículo científico publicado en 2018

Methodological issues in primary prevention trials for neurodegenerative dementia

artículo científico publicado en 2009

Military risk factors for Alzheimer's disease

artículo científico publicado en 2013

Military-related risk factors for dementia

article published in 2018

Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development

artículo científico publicado en 2016

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

artículo científico publicado en 2018

National Institute on Aging - Alzheimer's Association Research Framework lays the groundwork for deeper understanding of Alzheimer's disease

artículo científico publicado en 2018

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

artículo científico publicado en 2012

Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms

artículo científico publicado en 2017

Neuropsychiatric symptoms in Alzheimer's disease

artículo científico publicado en 2011

New and different approaches needed for the design and execution of Alzheimer's clinical trials

artículo científico publicado en 2013

Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease

artículo científico publicado en 2006

Partnership between academia and industry for drug discovery in Alzheimer's disease.

artículo científico publicado en 2008

Patient and Caregiver Assessment of the Benefits From the Clinical Use of Amyloid PET Imaging

artículo científico publicado en 2017

Perspective from the Alzheimer's Association: Neuroimaging Professional Interest Area of ISTAART continues impact on the field

artículo científico publicado en 2016

Perspective on everyday technologies for Alzheimer's care: research findings, directions, and challenges

artículo científico publicado en 2007

Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).

artículo científico

Potential roles of digital technologies in clinical trials

artículo científico publicado en 2017

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

artículo científico publicado en 2016

Prevention trials in Alzheimer's disease: an EU-US task force report.

artículo científico publicado en 2011

Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers

artículo científico publicado en 2012

Randomized controlled trials in mild cognitive impairment: Sources of variability

artículo científico publicado en 2017

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

artículo científico

Research and standardization in Alzheimer's trials: reaching international consensus

artículo científico

Research priorities to reduce the global burden of dementia by 2025.

artículo científico publicado en 2016

Revision of the criteria for Alzheimer’s disease: A symposium

artículo científico publicado en 2011

Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria

artículo científico publicado en 2013

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

artículo científico publicado en 2015

Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry.

artículo científico publicado en 2015

Scales as outcome measures for Alzheimer's disease

artículo científico publicado en 2009

Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative

artículo científico publicado en 2016

Shining a light on posterior cortical atrophy

artículo científico publicado en 2012

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

artículo científico publicado en 2017

Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective

artículo científico

Tau: From research to clinical development

artículo científico publicado en 2016

Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary

artículo científico publicado en 2016

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

artículo científico publicado en 2011

The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.

artículo científico publicado en 2018

The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update

artículo científico publicado en 2015

The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues

artículo científico publicado en 2017

The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions

artículo científico publicado en 2016

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

artículo científico publicado en 2011

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

artículo científico publicado en 2011

The effect of increased serotonergic neurotransmission on aggression: a critical meta-analytical review of preclinical studies

scientific article published on 30 April 2009

The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials

artículo científico publicado en 2012

The roles of inflammation and immune mechanisms in Alzheimer's disease

artículo científico publicado en 2016

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

artículo científico publicado en 2011

Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education

artículo científico publicado en 2013

Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging

artículo científico publicado en 2013

Vascular contributions to cognitive impairment and dementia including Alzheimer's disease

artículo científico publicado en 2015

Worldwide Alzheimer's disease neuroimaging initiative

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda